Fresenius a “Top Performer” in its Sector
Fresenius Medical Care is a leader in the MedTech sector, with a “Buy” rating from Zacks. An international company with a diversified product range, both revenue and net income to shareholders is expected to rise.
Read the full article » | Posted 04-12-2018
Related Articles
- 30th European Nephrology Conference will be held August 27-28 in Berlin Posted 02-17-2026
- An Australian PD patient developed the free Dialysis Health Tracker app Posted 02-17-2026
- Education Critical to Boosting Home Dialysis, Panel Says I Posted 01-16-2026
- The Annual Dialysis Conference Will be in Kansas City, MO February 26 to March 1 Posted 01-16-2026

